FDA product code MZP: Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
MZP is the FDA product code for assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus. It is a Class II device, regulated under 21 CFR 866.3170 and reviewed by the Microbiology panel. FDA has cleared 4 510(k) submissions under MZP, 4 in the last five years, from 3 different applicants. The average 510(k) review took 171 days (median 150); 192 days on average over the last three years. 9 PMA applications cite this product code. FDA has posted 11 recalls for MZP devices, 6 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus |
| Device class | Class II |
| Regulation | 21 CFR 866.3170 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
510(k) clearances per year for MZP
| Year | Clearances | Avg. review days |
|---|---|---|
| 2022 | 1 | 213 |
| 2024 | 1 | 299 |
| 2025 | 2 | 86 |
Compare with all 510(k) review times · Search every MZP clearance
Top MZP applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Roche Molecular Systems, Inc. | 2 | 2025-11-03 |
| Abbott Molecular, Inc. | 1 | 2025-09-25 |
| Hologic, Inc. | 1 | 2024-07-24 |
Most recent MZP clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252484 | Roche Molecular Systems, Inc. | cobas HCV | 2025-11-03 | 88 |
| K252102 | Abbott Molecular, Inc. | Alinity m HCV | 2025-09-25 | 84 |
| K233352 | Hologic, Inc. | Aptima HCV Quant Dx Assay | 2024-07-24 | 299 |
| K221007 | Roche Molecular Systems, Inc. | cobas HCV | 2022-11-04 | 213 |
Recalls for MZP devices
11 product recalls in 9 recall events; 6 initiated in the last five years and 3 still open. Most recent: 2023-10-30.
| Year | Recalls |
|---|---|
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
Frequently asked questions
What is FDA product code MZP?
MZP is the FDA product code for assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus. It is a Class II device, regulated under 21 CFR 866.3170 and reviewed by the Microbiology panel.
What device class is MZP?
Class II, regulation 21 CFR 866.3170. Typical premarket route: 510(k).
How long does a 510(k) take for product code MZP?
Across 4 cleared submissions the average was 171 days from receipt to decision (median 150).
Which companies have the most MZP clearances?
Roche Molecular Systems, Inc. (2); Abbott Molecular, Inc. (1); Hologic, Inc. (1).
Have MZP devices been recalled?
Yes: 11 product recalls across 9 recall events; the most recent began 2023-10-30.
Next steps
- Run an FDA pathway report with predicate devices for product code MZP
- Run a recall and safety report across every MZP manufacturer
- Watch product code MZP for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times